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Alternatives to mammalian testing are highly desirable to predict the skin sensitisation potential of 
agrochemical active ingredients (AI). The GARD assay, a stimulated, dendritic cell-like, cell line 
measuring genomic signatures, was evaluated using twelve AIs (seven sensitisers and five non-
sensitisers) and the results compared with historical results from guinea pig or local lymph node assay 
(LLNA) studies. Initial GARD results suggested 11/12 AIs were sensitisers and six concurred with 
mammalian data. Conformal predictions changed one AI to a non-sensitiser. An AI identified as non-
sensitising in the GARD assay was considered a potent sensitiser in the LLNA. In total 7/12 GARD results 
corresponded with mammalian data. AI chemistries might not be comparable to the GARD training set 
in terms of applicability domains. Whilst the GARD assay can replace mammalian tests for skin 
sensitisation evaluation for compounds including cosmetic ingredients, further work in agrochemical 
chemistries is needed for this assay to be a viable replacement to animal testing. The work conducted 
here is, however, considered exploratory research and the methodology needs further development to 
be validated for agrochemicals. Mammalian and other alternative assays for regulatory safety 
assessments of AIs must provide confidence to assign the appropriate classification for human health 
protection. 
 







Allergic contact dermatitis is caused by an adverse immune response to chemical haptens (Rustemeyer et 
al., 2012, Kaplan et al., 2012). For compounds such as agrochemicals, the identification of skin sensitising 
properties is an important part of regulatory hazard assessment to ensure safety during manufacture and 
use. Currently there is no globally harmonised position on the use of in vitro alternatives for regulatory 
purposes. Consequently, agrochemicals are routinely tested for skin sensitisation using in vivo tests such 
as the guinea pig tests and the local lymph node assay (LLNA) (Basketter et al., 2012, Gwaltney-Brant, 
2014). Recently attempts have been made to identify non animal-based methods with good predictive 
power for chemical hazard identification in a bid to reduce laboratory animal use (Alloul-Ramdhani et al., 
2014, Doe and Botham, 2019, Reisinger et al., 2015, Ivan de Ávila et al., 2019). In accordance with Article 
62 of the European Regulation (EC) No. 1107/2009, concerning the placing of plant protection products 
on the market; the use of in vivo mammalian test methods should only be used as a last resort. Where 
available non-animal test methods should be used and promoted ((EC), 2009) and several such in vitro 
assays have been developed for skin sensitisation. The Genomic Allergen Rapid Detection (GARD) assay is 
one of the more recent assays with as yet unknown potential for agrochemicals and therefore it was 
selected for evaluation in this investigation. 
 
The GARD assay is a cell-based, in vitro alternative to animal testing which assesses skin sensitisation by 
measuring the biomarker signature in chemical-stimulated, human MUTZ-3 cells (Johansson et al., 2011).  
The MUTZ-3 cell line serves as a surrogate for dendritic cells (DC) and changes in transcription in the genes 
can be linked to processes involved in skin sensitisation (Rovida et al., 2013, Masterson et al., 2002). The 
GARD assay measures transcriptional changes in 200 genes associated with sensitisation (Johansson et 
al., 2011). The 200 gene biomarker signature includes transcripts involved in oxidative stress, dendritic 
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cell maturation and cytokine responses (Johansson et al., 2011).  In particular, genes in pathways involved 
in dendritic cell maturation and activation, associated with key event three of the skin sensitisation 
adverse outcome pathway (AOP), which is also measured by the h-CLAT assay (OECD 2014, OECD 2018a), 
are included in the GARD assay. The Nrf-2 mediated oxidative response (Uruno and Motohashi, 2011), 
which is also the pathway measured in the KeratinoSens and LuSens assays (OECD 2018b, DB-ALM 
(INVITTOX), 2013) is included in the GARD assay. The results are then classified by a support vector 
machine (SVM) model trained on a set of reference chemicals (Forreryd et al., 2016). 
 
During the validation process of alternative methods for skin sensitisation, a wide array of test materials 
from different industrial sectors have been tested using the GARD (Johansson et al., 2019), and other, 
assays (OECD, 2018a). This has aided in ascertaining limitations and, more specifically, chemical types that 
do not fall within the applicability domain of each method. The GARD assay consistently reports accuracies 
of close to 90 to 95% compared to in vivo data (Johansson et al., 2017, Johansson et al., 2014, Johansson 
et al., 2013; Zeller et al., 2017). The evaluation of the GARD assay in a blind study using cosmetics 
ingredients (from Cosmetics Europe) demonstrated a predictive performance of 83% (Johansson et al., 
2017). Whilst the GARD assay has shown good performance in evaluation studies, it is worth noting that 
in vitro assays for skin sensitisation are not intrinsically standalone assays and none of them are perfectly 
predictive. However, they can be used a part of a weight of evidence approach, and as such, knowledge 




The aim of this study was to assess the in vitro GARD assay’s skin sensitisation predictivity in comparison 
with mammalian skin sensitisation tests on agrochemical active ingredients. To achieve this, agrochemical 
compounds for which sensitising potential had been previously established through GLP in vivo studies 
(OECD 429 murine local lymph node assays, OECD 406 guinea pig maximisation test and Buehler assays) 
were tested in the GARD assay. As a weight of evidence approach is advocated by the European Chemicals 
Agency (ECHA) when using in vitro data for the purpose of classification (ECHA 2017), a quantitative 
structure-activity relationship (QSAR) analysis of each of the test materials was also performed. Human 
data are available elsewhere for some of the active ingredients, however for the purposes of this 
evaluation these were not included as the comparison was with the available animal data. The mammalian 
studies are considered to be an appropriate standardised data set for comparison purposes.  
 
Materials and Methods 
 
GARD assay cell line 
The GARD assays were conducted by Senzagen (Lund, Sweden) on behalf of Syngenta according to the 
protocol as described in Forreryd et al., 2016 and Johansson et al., 2013. The human myeloid leukemia-
derived cell line SenzaCell (available through American Type Culture Collection (ATCC)) was used. This was 
maintained in α-minimum essential medium (Thermo Scientific Hyclone, USA) supplemented with 20% 
(volume/volume) foetal calf serum (Life Technologies, US) and 40 ng/ml recombinant human Granulocyte 
Macrophage Colony Stimulating Factor (rhGM-CSF) (Miltenyi Biotec, Germany). A medium change during 
cell expansion was performed every three to four days. Working stocks of cultures were grown for a 
maximum of 16 passages or two months after thawing. The chemically exposed cells were incubated for 





Test substances (Table 1) were dissolved in dimethylsulfoxide (DMSO) or water, based on physico-
chemical properties. The cytotoxic effects of test substances were monitored, as a concentration leading 
to 90% relative cell viability (Rv90) demonstrating the test substance’s toxicity, was used in the assay. The 
assayed test substances were titrated to concentrations ranging from 1 μM to the maximum soluble 
concentration in cell media. For freely soluble test substances, 500 μM was set as the upper limit of the 
titration range. For test substances dissolved in DMSO, the in-well concentration of DMSO was 0.1%. After 
incubation with the test substance for 24 hours, harvested cells were stained with the viability marker 
Propidium Iodide (PI) (BD Bioscience, USA) and analysed by flow cytometry. For non-toxic test substances, 
a concentration of 500 μM was used, if possible. When test substances were poorly dissolved in cell 
medium or insoluble at the 500 μM concentration, the highest soluble concentration was assessed and 
used. The concentration to be used for any given chemical is referred to as the GARD input concentration.  
 
 
Once the input concentration had been established, the cells were exposed solely to this concentration. 
A set of positive and negative controls were included as reference and quality controls. The test 
substances and controls were assayed in biological triplicates, performed at different timepoints and using 
different cell cultures. After incubation for 24h at 37°C, 5% CO2 and 95% humidity, the cell cultures were 
lysed in TRIzol reagent (Life Technologies, Carlsbad, California, USA) and stored at -20°C until RNA had 
been extracted. In parallel, stimulated cells were propidium iodide (PI) stained and analysed using flow 




RNA extraction and microarray hybridisation 
RNA extraction and cDNA hybridisation were conducted on NanoString measurements as described by 
Johansson and co-workers (2019). 
 
Agrochemicals 
Twelve agrochemical AIs were chosen to assess the GARD assay’s suitability to evaluate skin sensitisation 
of technical active ingredients alone. Seven of the AIs were recognised skin sensitisers based on in vivo 
data and where harmonised classifications have been assigned to them, these are presented in Table 1.  
The remaining five were considered to be non-sensitising substances (Table 1). For the purpose of this 
evaluation, no new mammalian tests were conducted and it was recognised that results from both guinea 
pig (Buehler or Maximisation Tests (GPMT)) and the (reduced) local lymph node assay (r)LLNA would be 
used to assess the skin sensitisation potential of the 12 agrochemical AIs under evaluation.  
Conformal predictions 
Whilst not a standard part of the GARD assay, as an additional analysis, conformal predictions were 
generated to demonstrate the similarity of the individual agrochemical AI test substances to the GARD 
training set of confirmed skin sensitisers and non-sensitisers. These were performed after the initial GARD 
skin predictions were generated for the test set and used to overrule or confirm the GARD prediction. 
Conformal prediction for the test substances examined were obtained by comparing the mean Decision 
Values to mean Decision Values of all reference items in the calibration dataset. Conformal predictions 
were used to demonstrate the similarity of the individual agrochemical AI test substances to the training 
set of confirmed sensitisers and non-sensitisers (Forreryd et al., 2018). The p-values generated were used 
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to score the difference (strangeness) between the result for any of the agrochemical AIs in the test set (as 
shown in Table 1) against the results of the sensitisers or non-sensitisers in the GARD training set 
chemicals. So, for example, where the p-value for chlorothalonil against the training set positive sensitiser 
results (Psens) is 0.76, we can say its non-conformity to that sensitising group was only 24%. Whereas its p-
value associated with the non-sensitising test set chemical results (Pnon-sens) of 0.05 indicated a non-
conformity to that group of 95%. This demonstrated a higher confidence that the GARD result obtained 
for chlorothalonil should indeed sit within the cluster of results for sensitising training set chemicals (Vovk, 
2005).    
 
Performance criteria  
In order to understand the GARD assay’s predictive power and the accuracy of its performance in 
comparison with the in vivo laboratory animal test data, statistical parameters were calculated between 
in vivo experimental and GARD in vitro assay result data. Sensitivity, specificity, total success/accuracy, 
positive and negative predictivity as well as the Cohen’s kappa coefficient were calculated to evaluate the 
performance of the GARD assay. These parameters were all calculated using the method described by 
Modi et al (2012). 
 
The differences in chemical characteristics between the GARD training set and agrochemical AI test set 
were also examined. This was performed by assessing the molecular weight, logarithm of the octanol-
water partition coefficient (log P) and numbers of hydrogen bond donors (HBD), hydrogen bond acceptors 
(HBA) and rotatable bonds (RB) present in each compound in the two chemical sets.  AlogP was used to 
calculate log P in accordance with the previous work by Guziałowska-Tic (Guziałowska-Tic, 2017) who 
demonstrated that AlogP provided the optimum conformity for this chemical property.  It should be noted 
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that Kathon CG/ICP is present in the GARD training set. In order to best capture the physicochemical 
properties of this preservative mixture, its two active components (Methylisothiazolinone and 
Methylchloroisothiazolinone) were entered individually into the data set for this evaluation.  
 
Evaluation of structural alerts for protein binding and skin sensitisation 
Structural alerts for protein binding and skin sensitisation (Aptula and Roberts, 2006, Enoch et al., 2011) 
were identified from the OECD QSAR Toolbox version 4.3 (https://www.oecd.org/chemicalsafety/oecd-
qsar-toolbox.htm) for the chemicals in both the training and test sets. The following profilers were 
applied:  
 Protein binding alerts for skin sensitisation by OASIS 
 Protein binding alerts for skin sensitisation by OASIS with skin metabolism 
 Protein binding alerts for skin sensitisation according to GHS  
 Protein binding alerts for skin sensitisation according to GHS with skin metabolism 
 
 
The alerts were assessed for their association with in vivo skin sensitisation. A compound was considered 
to be identified as a skin sensitiser if the OASIS/GHS profiler gave an outcome of 1A or 1B, or if the OASIS 
with skin metabolism profiler gave a 1A result. A non-sensitiser was concluded if the OASIS/GHS profiler 
identified no alert or if the OASIS/GHS with skin metabolism profiler gave a 1B result. The GARD assay 
does not encompass the metabolic system, consequently this was the rationale for rating OASIS with 






The aim of this research was to compare the results of the GARD assay to the available in vivo skin 
sensitisation study outcomes for twelve agrochemical AIs. The results from the GARD assay are 
summarised in Table 3.  
 
Analysis of Applicability Domain of the GARD Assay and Agrochemical AIs Tested 
Table 4 details the in vivo assay predictions compared to those of the GARD assay for this study’s test set. 
The GARD assay correctly predicted the six sensitisers, however, the negative predictivity of the GARD 
assay for the test set was not concordant with that of the in vivo results.  Performance analysis of these 
data using the statistical parameters was conducted as shown in Table 5 and illustrated in Figure 1. When 
compared to the in vivo results, the negative predictivity of the GARD assay was mainly nonconcordant 
for this test set, with a positive predictivity of 55%, sensitivity of 86% and a total accuracy of 50%. Cohen’s 
Kappa coefficient provided a statistical measure of inter-rater agreement for categorical items 
(sensitiser/non-sensitiser) and the value for Cohen’s Kappa value was -0.16 indicating poor agreement 
between sensitisers and non-sensitisers. 
 
In order to determine possible reasons for the nonconcordant results between the GARD assay and in vivo 
test results for the agrochemical AI test set, the ranges of physicochemical properties of the GARD training 
set and the AIs tested were compared. A broad overview of the range relative physicochemical properties 
which may affect solubility and uptake is provided as a plot in Figure 2. A range of physicochemical 
properties (i.e. calculated log P (AlogP) against molecular weight) associated with the AIs were plotted 
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against the published training set of the GARD assay. Figure 3 shows the comparison of the distribution 
of molecular weight for the GARD training set and the agrochemical AIs tested. The chemicals in the GARD 
training set had molecular weights of approximately 150Da and only two had molecular weights above 
300Da. The molecular weights of the agrochemical AIs tested were higher, with many approximately 
400Da and only two agrochemicals (dicamba and chlorothalonil) with molecular weights below 300Da. A 
comparison of the distribution of AlogP for the GARD training set and the agrochemical AIs tested is given 
in Figure 4. The majority of chemicals in the GARD training set have AlogP values in the range of 1, and 
only two were above 4. The majority of agrochemicals tested had an AlogP of approximately 4 and none 
had an AlogP value below 2.  In terms of the ranges of the two physicochemical properties considered, 
there is a difference between those of the GARD training set and the AIs tested.  
 
 
Following the conformal prediction analysis, the GARD assay result for dicamba was changed from a being 
a skin sensitiser to a non-sensitiser as shown in Table 6. This was due to the derived Pnon-sens value of 0.16, 
indicating that dicamba had non-conformity to the non-sensitising group of 84% as opposed to the 86% it 
demonstrated for the sensitising group.  
 
An evaluation of the physico-chemical similarities between the GARD training set (Forreryd et al., 2018)  
and the test set of 12 agrochemical AIs was performed and the results shown in Table 7. The evaluation 
focused upon the test materials’ log P, MW, HBA, HBD and RB, which are molecular descriptors often 
associated with membrane permeability and included in the defined rules for pesticide likeness (Avram 
et al., 2014). The HBA and RB also demonstrated a noticeable difference in recorded median values with 
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little difference between the two sets seen in HBD. Table 7 shows the differences between 
physicochemical values of the training and test set.   
 
An assessment of the chemical domains covered by both sets of chemicals was performed. The Venn 
diagram shown in Figure 5 indicates that the training set covers all the chemical domains identified in the 
agrochemical AI test set and also covers bimolecular nucleophilic substitution (SN2) which was not present 
in the test set.   
 
In Silico Evaluation  
Further evaluation using the OECD QSAR Toolbox comparing the in vivo study experimental results against 
the in silico profiling of both the agrochemical AI test set and GARD assay training set was performed. The 
structural alerts in the profilers were predictive of the skin sensitisation in vivo experimental outcome for 
the training set (Table 8).  
 
Discussion 
This study compared the predictions of the GARD assay to the results of previously conducted in vivo 
animal assays testing the skin sensitisation potential of 12 agrochemical AIs. The GARD assay identified 
ten of the test materials as skin sensitisers and two as non-sensitisers. The results from the GARD assay 
were not in agreement with the in vivo data for five of the 12 agrochemical AI materials tested. In order 
to ensure the veracity of the outcome of the GARD assay, conformal prediction analysis was performed, 




In Silico Evaluation – Mechanistic Chemistry and Physicochemical Property Domains 
In order to understand the performance of the GARD Assay compared to in vivo results for the AIs, their 
coverage in terms of mechanistic and chemical applicability domains was examined. First, an assessment 
was undertaken to comprehend the change in sensitisation outcome for dicamba using conformal 
prediction analysis (as shown in Table 6) and whether this could give an insight into domains. In this 
instance, it appears that this conformity exercise does not necessarily indicate if a chemical was within 
the appropriate applicability domain of the GARD assay, but rather, it indicates using the model’s own 
training set, within which of the two groups of potential outcomes, the test compound is most likely to 
fall. Thus, the conformal method would not necessarily be able to indicate how appropriate the GARD 
assay is for a chemical that falls outside of the chemical space of the training set used. As such it can be 
determined that the use of conformal predictions is not an appropriate method to ascertain whether the 
agrochemical AI test materials in this study fall within the current applicability domain of the GARD assay. 
 
To determine the possible role of mechanistic chemistry with regard to domain alerts flagged by the OECD 
QSAR Toolbox, each set of chemicals were investigated (note structural alerts are discussed in more detail 
below). No significant differences between the GARD assay training set and the agrochemical AI test set 
were observed during our evaluation. All of the chemical mechanisms of action important for skin 
sensitisation (Aptula and Roberts, 2006, Enoch et al., 2011) have been identified in the GARD assay 
training set. Thus, differences in the responses from the GARD assay and in vivo rodent skin sensitisation 
test results for the AIs tested, are not as a result of any specific chemical mechanism of action for skin 
sensitisation being absent in the GARD training set, as it encompassed all those identified in the 
agrochemical AI test set. Therefore, in order to further understand why the difference in results between 
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the GARD assay and in vivo experimental tests was observed, the physico-chemical properties of the 
chemicals in the GARD training set and the agrochemical test set were examined. 
 
The physicochemical property domains of the GARD training set and the 12 AIs tested were compared to 
provide further understanding of the differences observed between the predicted GARD results and the 
in vivo experimental results. The purpose of this analysis was to determine if the sets represented 
different areas of chemical space, as defined by the physicochemical properties considered. Such 
properties are a key component of the “applicability domain” of a test assay or QSAR and other 
components of the applicability domain (where relevant) include structural similarity, mechanism of 
action, metabolism, reactivity and toxicokinetics (Dimitrov et al., 2005, Netzeva et al., 2005, van der Laan 
et al., 2012). This analysis was not intended to be a full determination of the applicability domains of the 
AI test set and GARD assay training set. For skin sensitisation, a full analysis of applicability domain would 
include an analysis of the mechanistic reactivity domain associated with each chemical (Aptula et al., 2005, 
Aptula and Roberts, 2006, Roberts et al., 2007). However, definition and consideration of the physico-
chemical property ranges, such as compound solubility, is a key step in the assessment of technical 
limitations to assist in the evaluation and ultimate validation of an in vitro assay (Bruner et al., 1996, Worth 
and Balls, 2004) and assists in its correct usage. Following the evaluation of molecular descriptors of the 
test and training set chemicals, an apparent difference in molecular weights was observed between the 
test and training set, indicating that a higher molecular weight range is present in the agrochemical AI test 
set compared to that seen in the training set. Whilst the training set contained molecules with a molecular 
weight of predominantly 50-200Da, one further compound, Tween 80 with a molecular weight 833Da, 
was included in the training set. This compound is, however, benign, a non-sensitiser and is used regularly 
as a vehicle in toxicity studies. Thus, the inclusion of Tween 80 in the training set has expanded the 
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molecular weight range of this set and this range may not be representative of all the compounds 
contained within it. This is demonstrated by the median of the training set. 
 
There is a substantial difference between the molecular weight of Tween 80 and the nearest training set 
neighbour (penicillin). This indicated that the molecular weight of the test set of agrochemicals was not 
adequately represented within the GARD training set, however, it is acknowledged that these were well 
within the limits of absorption and skin penetration (Lipsinki et al, 2001). This means that there is a domain 
of chemical reactivity unaccounted for concerning the molecular weight of the penicillin compound in the 
training set. As many of the agrochemicals fall within this domain, confidence in the accuracy with which 
the GARD assay will be able to give the correct prediction may not be strong. 
  
In addition to the difference in molecular weight there is also a separation between the training set log P 
(with a range of -4.77 to 5.74 and median of 1.12) and the test set log P values (2.78 to 5.02 with a median 
of 3.94). In this context the initial GARD predictions cannot be considered robust based on the current 
test data used in the assay. It is well reported that molecular weight and log P have an influence on the 
rate of dermal absorption of chemicals (Potts and Guy, 1992). These chemical parameters have not been 
used in this study to aid in the evaluation of skin sensitisation potential, instead they have been used here 
to identify potential differences in the chemical space between the two sets of chemicals. It has been 
previously reported that the most marked difference in physico-chemical properties between 
pharmaceuticals and agrochemicals is the lower number of hydrogen bond donors (Clarke and Delaney, 
2003, Tice, 2001). Consequently the hydrogen bond donors (HBD), hydrogen bond acceptors (HBA) and 
rotating bonds (RB) in the training and test set groups have been compared (Clarke and Delaney, 2003). 
The addition of these three physico-chemical properties to this study’s evaluation enabled the complete 
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comparison of the chemical sets in accordance with Lipinski’s “rule of five” and Hao and coworkers’s rules 
for pesticide likeness (Avram et al., 2014, Clarke and Delaney, 2003, Barret, 2018, Lipinski et al., 2001, Hao 
et al., 2011). A clear difference in distribution can be observed in four of the five physico-chemical 
properties of the chemical sets that have been reviewed here. Thus, at this time there is insufficient 
evidence to suggest the GARD training set offers the width in range necessary to capture the agrochemical 
AI test set properties.  
 
Review of Structural Alerts  
The assessment of the presence of structural alerts for skin sensitisation, as identified from the OECD 
QSAR Toolbox, in the chemical structures  of the GARD assay training set and agrochemical AI test set, 
also provided predictions that, in comparison to the in vivo experimental data, overestimated the skin 
sensitisation potential of the test set. For the test set, there was 71% agreement between experimental 
sensitisation and predicted sensitisation. However, only 60% of the test set agrochemical AIs with in vivo 
non-sensitising results, were associated with structural alerts for protein binding (and hence skin 
sensitisation) by the OECD QSAR Toolbox. This overestimation of the sensitisation potential of the 
agrochemical AI test set is largely in keeping with the trend observed with the GARD assay results. It should 
be remembered that structural alerts for protein binding (related to skin sensitisation) in the OECD QSAR 
Toolbox have been developed from many sources including historical skin sensitisation data. For instance, 
Enoch et al (2008) developed a set of structural alerts for skin sensitisation based on historical LLNA data 
compiled by Gerberick et al (2005). These data, and a subsequent expanded LLNA data set (Kern et al 
2010), are predominantly for small, low molecular weight compounds, the majority of which are relevant 
as cosmetics ingredients or represent the chemical of cosmetic ingredient space with few, or no 




The results seen in the OECD QSAR Toolbox profiling suggest that differences in chemical space can also 
influence skin sensitisation outcome. It may be hypothesised that the structural alerts are more 
informative of the skin sensitisation potential of low molecular weight, cosmetic-like compounds than the 
potential for adverse outcomes in agrochemicals and specifically for our test set. In addition, the shift 
towards increased hydrophobicity and molecular weight in the agrochemical AIs compared to the training 
set values, indicates a potential for lower skin penetration which is not accounted for. This is in line with 
a previous publication by Basketter et al (1992) suggesting that an important factor governing the skin 
sensitisation potential of halogenated chemicals, such as bromoalkanes, is their skin penetration rate 
(Basketter et al., 1992). To attain a more predictive set of structural alerts for agrochemicals these 
additional physicochemical factors and skin penetration need to be accounted for, or a factor may need 
to be applied to account for the dermal absorption differences. This is also an important consideration for 
all in vitro assays for skin sensitisation and is often accommodated within the weight of evidence or as 
part of the risk assessment. 
  
To illustrate the issue of the assessment of halogenated compounds, dicamba is a chlorinated benzoic 
acid that has been used widely on a variety of crops as an effective herbicide for more than 50 years (Wang 
et al., 2016, Yao et al., 2015). Whilst some acids are included in the training set e.g. salicylic acid, lactic 
acid, benzoic acid, the GARD assay was unable to make an accurate prediction for dicamba. The GARD 
assay predicted dicamba to be a skin sensitiser, whilst the in vivo study and ECHA harmonised classification 
have not classified it as such. The acids present in the training set were not halogenated and the only 
compound present in the GARD training set that was halogenated was methylchloroisothiazolinone. As 
expected with agrochemicals (Jeschke, 2010), nine of the 12 compounds in the agrochemical AI test set 
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were halogenated. This further indicates the difference between the chemistry of the two chemical sets 
evaluated in this study. In particular, there was discordance between the GARD and in vivo results for 
pinoxaden, which had an identified EC3 value from a previously conducted LLNA corresponding to a 
harmonised classification Skin sens. Category 1A, H317 (ECHA, 2015, EFSA, 2013). This compound is 
outside of the applicability domain, however this does not fully explain why this assay was unsuccessful 
at predicting a potent sensitiser. A potential limitation of the in vivo methods may also have been a factor 
in the differences in results seen between the GARD assay and in vivo methods results. The highest test 
material dose that could be selected for the guinea pig or LLNA skin sensitisation tests is the maximum 
soluble concentration that does not induce systemic toxicity and/or excessive local irritation (OECD, 1992, 
OECD, 2010). Where observed toxicity of a given test material may have limited the highest concentration 
that could be tested in the in vivo experiments, the GARD assay was still able to use the high 
concentrations and investigate skin sensitisation potential at these levels. For these test substances, 
solubility and cytotoxicity were not limiting factors in the methodology as the maximum exposure 
concentration was used for negative outcomes. 
 
The chemical space disparity that has been identified between the GARD training set and the agrochemical 
AI test set may have occurred because the predictive model is a machine learning classifier (a support 
vector machine model) that has been trained on gene signals mainly for compounds used as, or similar 
to, cosmetics ingredients. The gene signal in relation to cosmetics ingredients has been learned by the 
model and chemicals of all domains are classified in this way. This gives each chemical a biological 
fingerprint relevant to cosmetics but not to agrochemicals.  
 
Future work and opportunities for further improvement 
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The results from the GARD assay indicate that the biological fingerprint (i.e. the changes in transcription 
in the genes in the Mutz-3 cells (surrogates for dendritic cells)) for skin sensitisation is not consistent 
across all chemicals. The GARD assay performed in the manner expected of it, in that it provided 
predictions of skin sensitisation potential for the agrochemical AI test set using the machine learnt, 
biological fingerprint provided by its training set. In an attempt to improve skin sensitisation predictivity 
for agrochemical compounds in the GARD assay in the future, additional compounds should be added to 
the GARD training set with molecular weights between 300- 800Da and ALogP values of 3-5. Halogenation 
has not been identified as a cause of sensitisation, however unlike cosmetics, agrochemicals are 
intentionally biologically active and frequently halogenated. This may skew or change the biological 
fingerprint of this chemical set in a manner that affects the prediction produced by the GARD assay in 
comparison to the in vivo experimental results. As noted above, halogenation of compounds is important 
when considering skin sensitisation (Basketter et al., 1992), and thus addition of halogenated compounds 
to the GARD assay training set may improve its capability to predict skin sensitisation of agrochemicals. 
The compounds added to the training set should include an increased number of different chemistries i.e. 
biocides and agrochemicals and this may aid to further investigate this hypothesis.   
 
The design of the training set for machine learning in the GARD assay is a key component to adequately 
establish an understanding of biological outputs and how they apply to the individual domains of the AIs 
tested. The application of structural alerts delivers a clear understanding of the applicability domain and 
is required to be able to identify limitations to mechanistic chemistry in the in vitro assay being evaluated. 
However, we have observed in this study that all reactivity domains present in the test set are covered by 
the training set, and yet a nonconcordant result is observed between the in vitro and in vivo test methods. 
We hypothesise that the physico-chemical parameters of the test and training chemical sets examined in 
this study also play a role in the setting of an applicability domain. This is in line with the previously made 
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assumption that similar predictivity can be achieved  for substances that are similar to those in the training 
set and that the applicability domain of a model would depend on the structural, physico-chemical and 
response information in the data  used for training a model (Wilm et al., 2018).  It is noteworthy that 12 
compounds is a small test set to evaluate the GARD assay.  The lack of overlap between the test and 
training set indicates that additional work needs to be conducted to address false positive and negative 
outcomes. 
 
Whilst the GARD assay is not an approved OECD test guideline, it has the potential to replace mammalian 
testing in a number of different chemistries as part of a weight of evidence. However, the above work has 
demonstrated the need for the GARD training set to be expanded, in particular to include agrochemical 
compounds that occupy a different chemical space in terms of size and hydrophobicity. Additional 
confidence needs to be demonstrated or limitations to the assay identified, before the GARD assay can 
become a standalone replacement to animal testing. Validation of new alternative methods using 
different chemistries to ensure robustness of in vitro assays and scientifically reliable results across 
chemical domains, is crucial. This is exploratory research and the GARD assay needs further development 
to be validated for agrochemicals in our endeavour to confidently replace mammalian studies.  
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Figure 1. Various statistical parameters adopted to evaluate prediction of skin sensitisation potential by the 






















Figure 2. The molecular weight and Log P values of both the GARD training set (Forreryd et al., 2018) and 







Figure 3.  The distribution of molecular weights of the GARD training set of compounds (Forreryd et al., 2018) 




Red Agrochemical test set 
Blue GARD training set 
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The Venn diagram of the chemical domains identified in the two chemical sets i.e. the GARD training set and the 






Table 1. The active ingredient, agrochemical use and in vivo skin sensitisation outcomes of agrochemical 




(F, H, I) * 
In Vivo Outcome In Vivo Study Skin Sensitisation Harmonised 
Classification Labelling and 




Not classified  




Skin Sens. 1, H317 (EFSA et al., 









Not classified  







Not classified  
(EFSA, 2011a, Harp, 2010, EPA, 













Skin Sens. 1A, H317 (EFSA, 
2013, FAO, 2016) 
SYN1 I Positive (EC3 =0.13%) LLNA No harmonised classification 
SYN2 I Positive (EC3 =1.1%) LLNA No harmonised classification 
SYN3 I Positive rLLNA No harmonised classification 
SYN4 I Negative rLLNA No harmonised classification 
SYN5 I Positive rLLNA No harmonised classification 
*F: fungicide, H: herbicide, I: insecticide   
**SYN1 - SYN5: anonymised agrochemical active ingredients  













OECD QSAR Toolbox prediction scheme  
  
Sensitiser OASIS GHS profiler - 1A or 1B 
  OASIS w/metabolism profiler - 1A 
Non-sensitiser OASIS GHS profiler - No alert  
  OASIS GHS w/metabolism profiler - 1B 
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Table 3.   Protein binding alerts*, in vivo study results, Rv90**, GARD input concentration, GARD skin results, 











(Mean ± SD) 
GARD skin 
result 
benzovindiflupyr  AC/SB LLNA negative 40 µM 40 µM 6.0±0.9 positive 
chlorothalonil  SNAr Buehler positive 0.5 µM 0.5 µM 4.6±1.4 positive 
clodinafop-propargyl  No alert GPMT positive - 100 µM 6.1±0.9 positive 
cyantraniliprole  AC/SB LLNA negative - 100 µM 3.4±0.7 positive 
dicamba  SB LLNA negative - 500 µM 0.0±0.8 positive 
difenoconazole  No alert Buehler negative 50 µM 50 µM 6.3±0.9 positive 
pinoxaden  No alert LLNA positive (EC3 =0.43%) - 500 µM -0.5±0.5 negative 
SYN1 SB/NA LLNA positive (EC3 =0.13%) - 100 µM 1.1±0.7 positive 
SYN2 No alert LLNA positive (EC3 =1.1%) 140 µM 140 µM 6.9±0.4 positive 
SYN3 MA rLLNA positive - 100 µM 3.4±0.6 positive 
SYN4 No alert rLLNA negative 250 µM  250 µM  6.4±0.4 positive 
SYN5 SNAr LLNA positive (EC3 = 0.9%) 50 µM 50 µM 4.4±0.5 positive 
* AC, Acylation; MA, Michael addition; NA, Nucleophilic addition; SB, Schiff base formation; SNAr, Aromatic nucleophilic substitution;  
**Reaction domains were assigned based on expert judgment using the chemistry defined in Enoch et al (2011)***Rv90 - concentration of test substance inducing 90% 
relative viability.  
Positive control p-phenylendiamine,  




Table 4. Test results of agrochemical test set in vivo skin sensitisation results versus the GARD assay results 
  Pred. Pos Pred. Neg. 
in vivo Obs. Pos. 6 1 




Table 5. Statistical parameters used for evaluation of the GARD assay predictions of the agrochemical test set 
results versus the in vivo skin sensitisation assay results 
Positive predictivity 54.5% 
Negative predictivity 0.0% 
Sensitivity 85.7% 
Specificity 0.0% 
Total Success/Accuracy 50.0% 
*kappa-value -0.16 
MCC -0.14 
















benzovindiflupyr  negative positive 0.84 0.02 sensitiser  
chlorothalonil  positive positive 0.76 0.05 sensitiser  
clodinafop-propargyl  positive positive 0.85 0.02 sensitiser  
cyantraniliprole  negative positive 0.63 0.05 sensitiser  
dicamba  negative positive 0.14 0.16 non-sensitiser 




values) negative 0.11 0.4 non-sensitiser  
SYN1 positive  positive 0.31 0.07 sensitiser  
SYN2 positive  positive 0.85 0 sensitiser  
SYN3 positive positive 0.63 0.05 sensitiser  
SYN4 negative positive 0.85 0 sensitiser  
SYN5 positive positive 0.72 0.05 sensitiser  
      
*A measure of the Test Item non-conformity compared to the calibration set. If the p-value is below the error level 0.15 the Test Item is strange compared to calibration 
sensitisers. A value of greater than 0.15 indicates that it belongs to the group sensitisers with 85% confidence. 
**A measure of the Test Item non-conformity compared to the calibration set. If the p-value is below the error level 0.15 the Test Item is strange compared to calibration 




Table 7. Test set versus training set molecular properties 











weight 30 to 834 106 138 164 221 to 473 349 377 402 
Log P 
-4.77 to 
5.74 0.18 1.12 2.17 2.78 to 5.02 3.44 3.94 4.28 
HBA 0 to 12 1 2 3 2 to 6 4.5 5 5 
HBD 0 to 3 0 1 2 0 to 2 0 0 0.25 
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Table 8. The OECD QSAR Toolbox prediction for skin sensitisation against the in vivo experimental results of the 














sens 85% 15% 
20 Exp-NS 20% 80% 
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sens 71% 29% 
5 Exp-NS 60% 40% 
12       
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